analysis of long-term exposure to momelotinib in the phase iii simplfy myelofibrosis trials
Published 3 years ago • 113 plays • Length 2:07Download video MP4
Download video MP3
Similar videos
-
3:56
results of the phase ii titan study of caplacizumab in patients with attp
-
4:04
results of phase ii trial to assess the efficacy and safety of idelalisib
-
1:31
pembrolizumab plus avd in chl: long-term follow-up of a phase ii study
-
1:37
long-term follow-up from a phase ii trial of olutasidenib in idh1-mutated aml
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
1:59
the optec study: evaluating outpatient step-up administration of teclistamab in pts with r/r myeloma
-
1:33
outcomes of reduced intensity allosct in patients with accelerated-phase myelofibrosis
-
2:12
results from phase i study of alnuctamab administered intravenously & subcutaneously in r/r myeloma
-
4:26
the adhd app you need! (best kept secret!)
-
40:33
open mics with dr. stites: “miraculous” new treatment for multiple myeloma
-
12:10
industry 4.0 examples
-
1:17
phase ii study of tosedostat in mds
-
2:42
results from a phase i study of cc-98633 in r/r myeloma
-
2:04
introducing a phase ib/ii trial to evaluate tasquinimod for the treatment of myelofibrosis
-
2:25
results from a phase i/ii trial of pirtobrutinib and lv20.19 for patients with r/r lymphomas
-
8:57
outcomes of sct in t-all and t-lbl
-
2:26
outcomes of patients with accelerated-phase myelofibrosis after reduced-intensity hsct
-
2:03
an update on the phase ii/iii imerge trial of imetelstat in lr-mds
-
5:07
daratumumab in the management of al amyloidosis
-
3:36
the long-term outcomes of consolidative allosct for bpdcn
-
3:28
results of the optimismm study for r/r multiple myeloma
-
1:39
phase i/ii trial of adct-602 in b-all